Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer.

Agus, David B

Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Apr 2005 - 2534-43 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S.

0732-183X

10.1200/JCO.2005.03.184 doi


Adult
Aged
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Breast Neoplasms
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Infusions, Intravenous
Male
Middle Aged
Neoplasms--drug therapy